Is Aplus Biotechnology stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Aplus Biotechnology pays dividends. Last time was Friday 9th of August 2024 where the investors holding the stock on Monday 15th of July 2024 were paid TWD2.72574 per share. Over the last 2 times between 2023 and 2024, Aplus Biotechnology has paid TWD3.42574 with an average of TWD1.71 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Aplus Biotechnology 10 years ago, but if you had invested on Friday 6th of January 2023 when the price was TWD50.20, you would have made a profit of TWD31.60 per share or 62.95%
Yes, the average daily trading liquidity for Aplus Biotechnology is TWD53 463 thousand. You should therefore be able to get in and out of your positions relatively fast.
Aplus Biotechnology has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.58, the company's ability to pay off the debt is good. The company has a very low net profit margin of 3.92%, which is challenging.
We have calculated the inflation risk for Aplus Biotechnology to be low [0.2 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.